HDAC6 at Crossroads of Infection and Innate Immunity

被引：36
|
作者：
Moreno-Gonzalo, Olga [1 ,2 ]
Mayor, Federico, Jr. [3 ,4 ]
Sanchez-Madrid, Francisco [1 ,2 ,4 ]
机构：
[1] CNIC, Vasc Pathophysiol Area, Cell Cell Commun Lab, Melchor Fernandez Almagro 3, Madrid 28029, Spain
[2] Univ Autonoma Madrid, Inst Invest Sanit La Princesa IIS IP, Hosp Univ Princesa, Serv Inmunol, Diego Leon 62, Madrid 28006, Spain
[3] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, Dept Biol Mol, E-28049 Madrid, Spain
[4] ISCIII CIBERCV, CIBER Enfermedades Cardiovasc, Madrid 28029, Spain
来源：
TRENDS IN IMMUNOLOGY | 2018年 / 39卷 / 08期
关键词：
D O I：
10.1016/j.it.2018.05.004
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Histone deacetylase 6 (HDAC6) acts by enzyme-dependent and-independent mechanisms to regulate diverse cellular processes including autophagy, the ubiquitin proteasome system, and cell migration. HDAC6 also has emerging roles in innate immunity, including pathogen sensing and destruction, thus placing this enzyme at the crossroads of infection and innate immunity.
引用
收藏
页码：591 / 595
页数：5
相关论文
共 50 条
  • [1] HDAC6, at the crossroads between cytoskeleton and cell signaling by acetylation and ubiquitination
    Boyault, C.
    Sadoul, K.
    Pabion, M.
    Khochbin, S.
    ONCOGENE, 2007, 26 (37) : 5468 - 5476
  • [2] HDAC6, at the crossroads between cytoskeleton and cell signaling by acetylation and ubiquitination
    C Boyault
    K Sadoul
    M Pabion
    S Khochbin
    Oncogene, 2007, 26 : 5468 - 5476
  • [3] High-selective HDAC6 inhibitor promotes HDAC6 degradation following autophagy modulation and enhanced antitumor immunity in glioblastoma
    Liu, Jia-Rong
    Yu, Chao-Wu
    Hung, Pei-Yun
    Hsin, Ling-Wei
    Chern, Ji-Wang
    BIOCHEMICAL PHARMACOLOGY, 2019, 163 : 458 - 471
  • [4] HDAC6 contributes to human resistance against Mycobacterium tuberculosis infection via mediating innate immune responses
    Zhang, Fuzhen
    Yu, Shanshan
    Chai, Qiyao
    Wang, Jing
    Wu, Tuoya
    Liu, Rongmei
    Liu, Yi
    Liu, Cui Hua
    Pang, Yu
    FASEB JOURNAL, 2021, 35 (11):
  • [5] The Role of HDAC6 in Cancer
    Aldana-Masangkay, Grace I.
    Sakamoto, Kathleen M.
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2011,
  • [6] HDAC6 bridges the gap
    Love, R
    LANCET NEUROLOGY, 2004, 3 (02): : 76 - 76
  • [7] Imaging HDAC6 in PTSD
    Bonomi, Robin
    Girgenti, Matthew
    Cosgrove, Kelly
    BIOLOGICAL PSYCHIATRY, 2024, 95 (10) : S247 - S247
  • [8] HDAC6 and Ovarian Cancer
    Haakenson, Joshua
    Zhang, Xiaohong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (05) : 9514 - 9535
  • [9] Deacetylation-dependent regulation of RIG-I activation by the HDAc6 deacetylase mediates innate anti-viral immunity
    Liu, Helene Minyi
    Loo, Yueh-Ming
    Hsiang, Tien-Ying
    Jiang, Fuguo
    Marcotrigiano, Joseph
    Gale, Michael, Jr.
    CYTOKINE, 2014, 70 (01) : 55 - 55
  • [10] Diverse roles of HDAC6 in viral infection: Implications for antiviral therapy
    Zhang, Linlin
    Ogden, Angela
    Aneja, Ritu
    Zhou, Jun
    PHARMACOLOGY & THERAPEUTICS, 2016, 164 : 120 - 125
12345